Page 136«..1020..135136137138..150160..»

Oregon baby undergoes fetal surgery for spina bifida | kgw.com

Posted: November 24, 2022 at 12:29 am

Michelle Johnson and Jeff Maginnis got word at her 20-week ultrasound that her developing baby was diagnosed with spina bifida.

DAMASCUS, Ore. An Oregon baby became the second person in the world to undergo a ground breaking surgery after he was diagnosed with spina bifida while still in the womb.

Tobi Maginnis, now 8 months old, was born happy and healthy thanks to the procedure by a team of doctors at the University of California, Davis.

At home in Damascus, Tobi Maginnis is all smiles and laughs.

"Even when we were in [the] NICU, he smiled and he would laugh in his sleep as a baby. Three days old, laughing in his sleep," said Michelle Johnson and Jeff Maginnis, Tobi's parents.

That joy extends to their entire family after a long journey to get to this point.

"Jeff and I met and I have a 13-year-old son and Jeff has a 6-year-old daughter and we decided we needed one more to complete our family," Johnson said.

But after Johnson's 20-week ultrasound last year, the couple learned some distressing news during a call with the radiologist.

"His voice was just trembling," Johnson said. "He says, 'I need to talk to you about your ultrasound.' And I knew something was wrong. He said 'There's some abnormalities. It appears to be spina bifida.'"

According to health experts, spina bifida occurs when spinal tissue fails to fuse properly during the early stages of pregnancy, leading to a range of lifelong cognitive, mobility, urinary and bowel disabilities. It affects 1,500 to 2,000 children in the U.S. each year.

"Just kind of shock," Maginnis said about learning of the diagnosis. "There's this very serious problem with your fetus, with your baby. What do you do? How do you react? How do you move forward?"

Because options in Oregon for fetal surgery were extremely limited, the couple had to look outside the state. This led them to UC Davis and a clinical trial that makes use of stem cells to treat spina bifida. The clinical trial, known formally as the CuRe Trial: Cellular Therapy for In Utero Repair of Myelomeningocele, is funded by the states stem cell agency, California Institute for Regenerative Medicine.

"I tell [Jeff] all the time, I would rather be in the CuRe trial than win the Powerball because of how rare and exclusive it is, and how life-changing it's been for our son."

After several screenings, interviews and acceptance into the trial, the couple moved down to California. She was the second patient to enroll in the trial.

"I think I was nervous, but I was also relieved knowing we're pursuing the best option for our baby," Johnson said.

Despite fears and concerns, with the help of a 40 person team, the surgery was a success. At 25 weeks gestation, Johnson had the landmark fetal surgery and stem cell procedure, where stem cells were placed directly on her fetuss spinal cord using a special patch to repair the spina bifida defect, according to UC Davis.

The couple spent the rest of the pregnancy in California, with a C-section scheduled at 36 weeks.

"They put the drape down and they held Tobi up. It was like Simba in the The Lion King. A Pride Rock moment," Johnson said. "And then Jeff said, 'It's a boy!' And that's how we found out Tobi was a boy."

Born February 1, 2022, Tobi is happy, healthy and full of personality.

"Tobi is the second baby in the entire world to receive stem cells during gestational surgery for spina bifida repair," Johnson said.

She praised the staff at UC Davis for their work and called them "talented."

"After 10 years of animal trials, to finally be able to do this on humans, this is exciting and I just hope it continues to become more available for all moms," Johnson said.

At this point, Tobi doesn't need any more procedures, but doctors will monitor his progress for several more years so the team can continue to assess the stem cell surgical procedure's safety and effectiveness.

Original post:
Oregon baby undergoes fetal surgery for spina bifida | kgw.com

Posted in Oregon Stem Cells | Comments Off on Oregon baby undergoes fetal surgery for spina bifida | kgw.com

Human Y-chromosome DNA haplogroup – Wikipedia

Posted: November 24, 2022 at 12:28 am

Human DNA groupings

In human genetics, a human Y-chromosome DNA haplogroup is a haplogroup defined by mutations in the non-recombining portions of DNA from the male-specific Y chromosome (called Y-DNA). Many people within a haplogroup share similar numbers of short tandem repeats (STRs) and types of mutations called single-nucleotide polymorphisms (SNPs).[2]

The human Y-chromosome accumulates roughly two mutations per generation.[3] Y-DNA haplogroups represent major branches of the Y-chromosome phylogenetic tree that share hundreds or even thousands of mutations unique to each haplogroup.

The Y-chromosomal most recent common ancestor (Y-MRCA, informally known as Y-chromosomal Adam) is the most recent common ancestor (MRCA) from whom all currently living humans are descended patrilineally. Y-chromosomal Adam is estimated to have lived roughly 236,000 years ago in Africa. By examining other bottlenecks most Eurasian men (men from populations outside of Africa) are descended from a man who lived in Africa 69,000 years ago (Haplogroup_CT). Other major bottlenecks occurred about 50,000 and 5,000 years ago and subsequently the ancestry of most Eurasian men can be traced back to four ancestors who lived 50,000 years ago, who were descendants of African (E-M168).[4][5][6][clarification needed]

Y-DNA haplogroups are defined by the presence of a series of Y-DNA SNP markers. Subclades are defined by a terminal SNP, the SNP furthest down in the Y-chromosome phylogenetic tree.[7][8] The Y Chromosome Consortium (YCC) developed a system of naming major Y-DNA haplogroups with the capital letters A through T, with further subclades named using numbers and lower case letters (YCC longhand nomenclature). YCC shorthand nomenclature names Y-DNA haplogroups and their subclades with the first letter of the major Y-DNA haplogroup followed by a dash and the name of the defining terminal SNP.[9]

Y-DNA haplogroup nomenclature is changing over time to accommodate the increasing number of SNPs being discovered and tested, and the resulting expansion of the Y-chromosome phylogenetic tree. This change in nomenclature has resulted in inconsistent nomenclature being used in different sources.[2] This inconsistency, and increasingly cumbersome longhand nomenclature, has prompted a move toward using the simpler shorthand nomenclature.

Haplogroup A is the NRY (non-recombining Y) macrohaplogroup from which all modern paternal haplogroups descend. It is sparsely distributed in Africa, being concentrated among Khoisan populations in the southwest and Nilotic populations toward the northeast in the Nile Valley. BT is a subclade of haplogroup A, more precisely of the A1b clade (A2-T in Cruciani et al. 2011), as follows:

The defining mutations separating CT (all haplogroups except for A and B) are M168 and M294. The site of origin is likely in Africa. Its age has been estimated at approximately 88,000 years old,[11][12] and more recently at around 100,000[13] or 101,000 years old.[14]

The groups descending from haplogroup F are found in some 90% of the world's population, but almost exclusively outside of sub-Saharan Africa.

FxG,H,I,J,K is rare in modern populations and peaks in South Asia, especially Sri Lanka.[10] It also appears to have long been present in South East Asia; it has been reported at rates of 45% in Sulawesi and Lembata. One study, which did not comprehensively screen for other subclades of F-M89 (including some subclades of GHIJK), found that Indonesian men with the SNP P14/PF2704 (which is equivalent to M89), comprise 1.8% of men in West Timor, 1.5% of Flores 5.4% of Lembata 2.3% of Sulawesi and 0.2% in Sumatra.[15][16] F* (FxF1,F2,F3) has been reported among 10% of males in Sri Lanka and South India, 5% in Pakistan, as well as lower levels among the Tamang people (Nepal), and in Iran. F1 (P91), F2 (M427) and F3 (M481; previously F5) are all highly rare and virtually exclusive to regions/ethnic minorities in Sri Lanka, India, Nepal, South China, Thailand, Burma, and Vietnam. In such cases, however, the possibility of misidentification is considered to be relatively high and some may belong to misidentified subclades of Haplogroup GHIJK.[17]

Haplogroup G (M201) originated some 48,000 years ago and its most recent common ancestor likely lived 26,000 years ago in the Middle East. It spread to Europe with the Neolithic Revolution.

It is found in many ethnic groups in Eurasia; most common in the Caucasus, Iran, Anatolia and the Levant. Found in almost all European countries, but most common in Gagauzia, southeastern Romania, Greece, Italy, Spain, Portugal, Tyrol, and Bohemia with highest concentrations on some Mediterranean islands; uncommon in Northern Europe.[18][19]

G-M201 is also found in small numbers in northwestern China and India, Bangladesh, Pakistan, Sri Lanka, Malaysia, and North Africa.

Haplogroup H (M69) probably emerged in South Central Asia or South Asia, about 48,000 years BP, and remains largely prevalent there in the forms of H1 (M69) and H3 (Z5857). Its sub-clades are also found in lower frequencies in Iran, Central Asia, across the middle-east, and the Arabian peninsula.

However, H2 (P96) is present in Europe since the Neolithic and H1a1 (M82) spread westward in the Medieval era with the migration of the Roma people.

Haplogroup I (M170, M258) is found mainly in Europe and the Caucasus.

Haplogroup J (M304, S6, S34, S35) is found mainly in the Middle East and South-East Europe.

Haplogroup K (M9) is spread all over Eurasia, Oceania and among Native Americans.

K(xLT,K2a,K2b) that is, K*, K2c, K2d or K2e is found mainly in Melanesia, Aboriginal Australians, India, Polynesia and Island South East Asia.

Haplogroup L (M20) is found in South Asia, Central Asia, South-West Asia, and the Mediterranean.

Haplogroup T (M184, M70, M193, M272) is found at high levels in the Horn of Africa (mainly Cushitic-speaking peoples), parts of South Asia, the Middle East, and the Mediterranean. T-M184 is also found in significant minorities of Sciaccensi, Stilfser, Egyptians, Omanis, Sephardi Jews,[20] Ibizans (Eivissencs), and Toubou. It is also found at low frequencies in other parts of the Mediterranean and South Asia.

The only living males reported to carry the basal paragroup K2* are indigenous Australians. Major studies published in 2014 and 2015 suggest that up to 27% of Aboriginal Australian males carry K2*, while others carry a subclade of K2.

Haplogroup N (M231) is found in northern Eurasia, especially among speakers of the Uralic languages.

Haplogroup N possibly originated in eastern Asia and spread both northward and westward into Siberia, being the most common group found in some Uralic-speaking peoples.

Haplogroup O (M175) is found with its highest frequency in East Asia and Southeast Asia, with lower frequencies in the South Pacific, Central Asia, South Asia, and islands in the Indian Ocean (e.g. Madagascar, the Comoros).

No examples of the basal paragroup K2b1* have been identified. Males carrying subclades of K2b1 are found primarily among Papuan peoples, Micronesian peoples, indigenous Australians, and Polynesians.

Its primary subclades are two major haplogroups:

Haplogroup P (P295) has two primary branches: P1 (P-M45) and the extremely rare P2 (P-B253).[21]

P*, P1* and P2 are found together only on the island of Luzon in the Philippines.[21] In particular, P* and P1* are found at significant rates among members of the Aeta (or Agta) people of Luzon.[22] While, P1* is now more common among living individuals in Eastern Siberia and Central Asia, it is also found at low levels in mainland South East Asia and South Asia. Considered together, these distributions tend to suggest that P* emerged from K2b in South East Asia.[22][23]

P1 is also the parent node of two primary clades:

Haplogroup Q (MEH2, M242, P36) found in Siberia and the AmericasHaplogroup R (M207, M306): found in Europe, West Asia, Central Asia, and South Asia

Q is defined by the SNP M242. It is believed to have arisen in Central Asia approximately 32,000 years ago.[24][25] The subclades of Haplogroup Q with their defining mutation(s), according to the 2008 ISOGG tree[26] are provided below. ss4 bp, rs41352448, is not represented in the ISOGG 2008 tree because it is a value for an STR. This low frequency value has been found as a novel Q lineage (Q5) in Indian populations[27]

The 2008 ISOGG tree

Haplogroup R is defined by the SNP M207. The bulk of Haplogroup R is represented in the descendant subclade R1 (M173), which likely originated on the Eurasian Steppes. R1 has two descendant subclades: R1a and R1b.

R1a is associated with the proto-Indo-Iranian and Balto-Slavic peoples, and is now found primarily in Central Asia, South Asia, and Eastern Europe.

Haplogroup R1b is the dominant haplogroup of Western Europe and is also found sparsely distributed among various peoples of Asia and Africa. Its subclade R1b1a2 (M269) is the haplogroup that is most commonly found among modern Western European populations, and has been associated with the Italo-Celtic and Germanic peoples.

This article needs to be updated. Please help update this article to reflect recent events or newly available information. (February 2021)

Footnotes

Here is the original post:
Human Y-chromosome DNA haplogroup - Wikipedia

Posted in Human Genetics | Comments Off on Human Y-chromosome DNA haplogroup – Wikipedia

Abstracts | International Congress of Human Genetics 2023

Posted: November 24, 2022 at 12:28 am

The International Scientific Programme Committee (ISPC) invites you to contribute to the programme by submitting an abstract for possible inclusion in the 14th International Congress of Human Genetics (ICHG) 2023 programme.

Please follow the abstract guidelines below, to help you through the submission process.

Abstract GuidelinesUse Arial Font 11, single line spacing and full justification for the borders.

Abstract Title:A brief title that clearly indicates the content of the contribution (maximum of 30 words).

Please avoid abbreviations in the abstract title. Abbreviations may be used if they refer to gene names using the standardised nomenclature, and in the body of the abstract if defined when first used. Do not use capitals or capitalise words that are not nouns.

Example:Title: This is an important African contribution to the field in terms of the APOL1 gene

Abstract Content:Please ensure that your abstract summarises your entire contribution in one paragraph (maximum of 300 words). Do not use section headings, but ensure that the content is structured.

Diagrams, illustrations, tables, references and graphics are NOT permitted.

Qualities of a good abstract embodies the following structure:

Check grammar and spelling, sentence construction and punctuation before submission. Ensure that abbreviations are defined when used for the first time and then use the abbreviation in the rest of the abstract. Only use abbreviations if the term is used two or more times. Ask another person to carefully proofread and check your abstract for flow and content, as well as the details above.

Note: Abstracts not in the correct format will be returned to the submitting author.

Keywords:Please indicate at least 3 keywords for your abstract. These terms will be used to help people locate your abstract using the Conference App.

Visit link:
Abstracts | International Congress of Human Genetics 2023

Posted in Human Genetics | Comments Off on Abstracts | International Congress of Human Genetics 2023

Nurses: The Frontlines of Preventative Care – Bradley University Online

Posted: November 24, 2022 at 12:25 am

According to the American Nurses Association, in addition to duties such as taking vital signs, administering medications, making physical assessments, delivering test results and assisting physicians, nurses also play a significant role in disseminating important health information. By offering education and counseling, nurses significantly can aid in preventative health efforts nationwide. Preventative health refers to a collection of strategies that health care professionals encourage patients to implement to help stay healthy and reduce the risk of future disease.

When one thinks of health care, notions of treatment and management for existing medical conditions come to mind. A major component of health care, however, also involves the prevention of illness. Known as preventative health care, a number of strategies fall under this banner. A United Healthcare fact sheet details that procedures performed in a doctors office, such as physical examinations, drawing blood for testing, immunizations and screenings for certain illnesses can be considered preventative health care measures. This classification is used because the procedures are performed in order to uncover illness in its early stages or to look for signs that may indicate elevated risk for certain conditions.

A health care professional will screen for certain kinds of cancers colon and breast cancer as these diseases are typically far easier to treat if they are discovered in their earliest stages, before the onset of symptoms. A primary care provider also may test a patients blood sample for evidence of problems that could lead to disease further down the road: High cholesterol and high blood pressure can foreshadow the development of heart disease, for example.

As noted in the United Healthcare article, preventative measures such as screenings, physical examinations and immunizations often are implemented in accordance with demographic factors like age, gender and family history. A fact sheet from the U.S. Centers for Disease Control and Prevention (CDC) detailed one such example, being colorectal cancer, which is widely screened for but only in adults over the age of 50. The CDC suggests the age threshold of 50 because adults younger than this are statistically at a much lower risk for exhibiting with disease.

Health promotion is another component of preventative health care that is understood by the World Health Organization. This term denotes the practice of educating and encouraging individuals to take greater care of their own health by effectively managing any chronic conditions they may have and taking lifestyle steps to reduce the risk of illness. One component of health promotion may be education about nutrition and exercise or smoking cessation.

As detailed in a CDC guide, preventative health care strategies are introduced to keep the population as healthy and disease free as possible. After all, according to CDC statistics, a majority of the deaths recorded across the U.S. each year around seven in 10 are caused by chronic conditions that are largely preventable. For example, the leading cause of death in the U.S., as reported by journalist Hannah Nichols in Medical News Today, is heart disease, with cancer and respiratory diseases coming in second and third place, respectively.

In addition to helping curtail rates of disease, preventative health measures help reduce health care costs and the burden on vital services. They also help to keep people active and productive in society. Preventable chronic illnesses can keep people away from work, with illnesses such as obesity, high blood pressure and asthma being particularly costly to the economy in terms of lost workdays. The CDC fact sheet also stated that preventative health care is an effective way to help seniors stay as healthy as possible into an advanced age a period when the risk of chronic conditions increases.

In a study published by the U.S. National Library of Medicine, Patricia Chiverton et al hightlights the importance for nursing professional working on the frontlines of patient care to aid with preventative health care efforts. Nurses achieve this primarily through the dissemination of information that patients can harness to keep themselves as healthy as possible. The authors note that the growing emphasis on preventative health care differs somewhat from historical nursing practice, which previously was centered almost exclusively on disease management.

Nursing staff can help advance preventative health care efforts in a number of ways, with some of the most impactful including the following:

According to Hospital News, one of the most fundamental ways that nurses assist inpreventative health efforts is through education. Nurses are qualified to talk to patients about a range of health-related topics, from nutrition and exercise, to other forms of disease prevention like practicing safe sex and refraining from drugs and excessive alcohol use. Education can be delivered in a number of ways and in many contexts. Nursing professionals may choose to host informational sessions about particular topics, or they may pass on written educational materials to patients, such as brochures and links to online resources.

The Hospital News article also cited a study that explained how nurses can use patient visits as an opportunity to initiate preventative health discussions. If a patient comes in with joint pain, a nurse can initiate a conversation about how excess weight can exacerbate pain before introducing weight management strategies. If a young patient seeks medical assistance with a chronic cough, a nurse can seize the moment to initiate a conversation about smoking cessation. Nursing staff essentially can promote health information and wellness strategies whenever they meet patients, helping disseminate important health information in the wider community.

365 Healthcare Staffing Services President Aaron Kasdorf posted to LinkedIn explaining how the most imperative part of any preventative health care strategy is paying particular attention to demographics of patients with a high risk for certain diseases. The second most important aspect of preventative health is providing information about strategies for better health, as well as facilitating any necessary screenings. For example, patients with a family history of heart disease should be encouraged to receive routine cholesterol and blood pressure testing, and nurses should offer advice about how exercise and good nutrition can help support heart health. Another demographic that tends to need more preventative health guidance is the population of older adults, as they are at a statistically higher risk for a range of chronic conditions, including diabetes, stroke and osteoporosis.

Kasdorf explained that it is common for patients to remain uncertain or in the dark as to the kinds of services they are entitled to under their health plans. Consequently, many miss out on vital preventative services, such as cancer screenings, blood testing and immunizations. Nurses are able to counsel patients on the details of their health plans and help connect individuals with the services they need and are entitled to.

According to the Nursing Council of Hong Kong, nurses also can help expand communitywide health care education. Nursing professionals can partner with local organizations, such as community centers or faith-based groups, to hold events pertaining to public health a lecture on good nutrition, a blood drive or a free cancer screening event. The nurses role can extend beyond a medical practice and into the community at large.

Nurse managers can actively help ensure that nursing professionals provide the best possible health education to patients. If you are eager to climb the career ladder and lead a dedicated team of nurses, consider applying to Bradley Universitys Master of Science in Nursing or Doctor of Nursing Practice Leadership program. Designed to help you study at a time that best complements your professional schedule, all coursework can be completed online with practicums you can set up and complete locally.

Recommended Reading

Nursing Jobs: Hospital or Private Practice

Is a Public Health Nursing Career Right for You?

Bradley University Online Nursing Programs

Sources

https://www.uhc.com/health-and-wellness/family-health/preventive-care

http://hospitalnews.com/the-role-of-the-nurse-in-health-promotion/

https://www.linkedin.com/pulse/role-nurses-preventive-health-care-aaron-kasdorf

http://www.nursingworld.org/EspeciallyForYou/What-is-Nursing/Tools-You-Need/RNsAPNs.html

https://www.cdc.gov/healthcommunication/toolstemplates/entertainmented/tips/preventivehealth.html

https://www.ncbi.nlm.nih.gov/pubmed/14621418

http://www.nchk.org.hk/filemanager/en/pdf/health_promotion_e.pdf

https://www.cdc.gov/cancer/colorectal/basic_info/screening/index.htm

http://www.who.int/topics/health_promotion/en/

https://www.cdc.gov/features/preventionstrategy/

http://www.medicalnewstoday.com/articles/282929.php

Go here to see the original:
Nurses: The Frontlines of Preventative Care - Bradley University Online

Posted in Preventative Medicine | Comments Off on Nurses: The Frontlines of Preventative Care – Bradley University Online

The Stem Cell Debate: Is it Over? – University of Utah

Posted: November 24, 2022 at 12:22 am

Regulations and policies change frequently to keep up with the pace of research, as well as to reflect the views of different political parties. Here President Obama signs an executive order on stem cells, reversing some limits on federal research funding. (White House photo by Chuck Kennedy)

Governments around the globe have passed legislation to regulate stem cell research. In the United States, laws prohibit the creation of embryos for research purposes. Scientists instead receive "leftover" embryos from fertility clinics with consent from donors. Most people agree that these guidelines are appropriate.

Disagreements surface, however, when political parties debate about how to fund stem cell research. The federal government allocates billions of dollars each year to biomedical research. But should taxpayer dollars be used to fund embryo and stem cell research when some believe it to be unethical? Legislators have had the unique challenge of encouraging advances in science and medicine while preserving a respect for life.

U.S. President Bush, for example, limited federal funding to a study of 70 or so hES cell lines back in 2001. While this did slow the destruction of human embryos, many believe the restrictions set back the progress of stem cell research.

President Obama overturned Bush's stem cell policy in 2009 to expand the number of stem cell lines available to researchers. Policy-makers are now grappling with a new question: Should the laws that govern other types of pluripotent stem cells differ from those for hES cells? If so, what new legislation is needed?

More:
The Stem Cell Debate: Is it Over? - University of Utah

Posted in Utah Stem Cells | Comments Off on The Stem Cell Debate: Is it Over? – University of Utah

FDA Approves First Gene Therapy to Treat Adults with Hemophilia B – FDA.gov

Posted: November 24, 2022 at 12:21 am

  1. FDA Approves First Gene Therapy to Treat Adults with Hemophilia B  FDA.gov
  2. Gene therapy at $3.5m a dose approved for US adults with hemophilia B  The Guardian
  3. FDA approves gene therapy for hemophilia  Axios
  4. FDA Approves Hemgenix, First Gene Therapy to Treat Adults with Hemophilia B  Everyday Health
  5. Costing $3.5M, first hemophilia B gene therapy wins FDA approval  FiercePharma
  6. View Full Coverage on Google News

Go here to read the rest:
FDA Approves First Gene Therapy to Treat Adults with Hemophilia B - FDA.gov

Posted in Gene therapy | Comments Off on FDA Approves First Gene Therapy to Treat Adults with Hemophilia B – FDA.gov

Cidara Therapeutics to Participate in the World Antiviral Congress 2022

Posted: November 24, 2022 at 12:18 am

SAN DIEGO, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed to improve the standard of care for patients facing serious diseases, today announced that Jeff Stein, Ph.D., President and CEO, will participate in a panel discussion at the World Antiviral Congress being held in San Diego, California from November 28-December 1, 2022.

Read the rest here:
Cidara Therapeutics to Participate in the World Antiviral Congress 2022

Posted in Global News Feed | Comments Off on Cidara Therapeutics to Participate in the World Antiviral Congress 2022

Oncorus to Participate in Upcoming Investor Conferences

Posted: November 24, 2022 at 12:18 am

ANDOVER, Mass., Nov. 23, 2022 (GLOBE NEWSWIRE) -- Oncorus, Inc. (Nasdaq: ONCR), a viral immunotherapies company focused on driving innovation to transform outcomes for cancer patients, today announced that President and Chief Executive Officer, Theodore (Ted) Ashburn, M.D., Ph.D., will participate in two upcoming investor conferences:

Read the rest here:
Oncorus to Participate in Upcoming Investor Conferences

Posted in Global News Feed | Comments Off on Oncorus to Participate in Upcoming Investor Conferences

NewAmsterdam Pharma Debuts as Publicly Traded Company Focused on Developing Obicetrapib, a Low-Dose, Once-Daily Oral LDL-Lowering Agent with Promising…

Posted: November 24, 2022 at 12:17 am

-- Business combination transaction with Frazier Lifesciences Acquisition Corporation, a special purpose acquisition company sponsored by an affiliate of Frazier Healthcare Partners, completed on November 22, 2022 ---- Closed concurrent, oversubscribed and upsized approximately $235 million private investment in public equity (“PIPE”), led by Frazier Healthcare Partners and Bain Capital Life Sciences --

See original here:
NewAmsterdam Pharma Debuts as Publicly Traded Company Focused on Developing Obicetrapib, a Low-Dose, Once-Daily Oral LDL-Lowering Agent with Promising...

Posted in Global News Feed | Comments Off on NewAmsterdam Pharma Debuts as Publicly Traded Company Focused on Developing Obicetrapib, a Low-Dose, Once-Daily Oral LDL-Lowering Agent with Promising…

Rain Therapeutics Announces a Poster Presentation at the 2022 San Antonio Breast Cancer Symposium

Posted: November 24, 2022 at 12:17 am

NEWARK, Calif., Nov. 23, 2022 (GLOBE NEWSWIRE) -- Rain Therapeutics Inc. (NasdaqGS: RAIN), (Rain), a late-stage biotechnology company developing precision oncology therapeutics with a lead product candidate, milademetan, an oral, small molecule inhibitor of the MDM2-p53 complex that reactivates p53, today announced a poster presentation at the upcoming 2022 San Antonio Breast Cancer Symposium (SABCS) taking place on December 6-10, 2022 in San Antonio, TX.

See the original post:
Rain Therapeutics Announces a Poster Presentation at the 2022 San Antonio Breast Cancer Symposium

Posted in Global News Feed | Comments Off on Rain Therapeutics Announces a Poster Presentation at the 2022 San Antonio Breast Cancer Symposium

Page 136«..1020..135136137138..150160..»